Trial intelligence / Profile preview

Basiliximab and delayed tacrolimus in liver transplant

NCT02123108Phase 4Completed

Sponsor
University of California, Los Angeles
Start
Jan 2011
Primary completion
Jan 2015
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of basiliximab in liver transplantation, sponsored by University of California, Los Angeles. Started Jan 2011; status: completed.

02

Drugs

basiliximab
03

Conditions

liver transplantation

Beyond the preview

Go deeper on NCT02123108.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02123108.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call